
NEOG Earnings Date: Jan 14, 2027 (Estimated) — Neogen Corporation
NASDAQ · Healthcare · Diagnostics & Research
Updated
When is NEOG's next earnings date?
Neogen Corporation (NEOG) is expected to report Q2 2027 earnings on Thursday, January 14, 2027 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.09 on revenue of $228.6M.
How did NEOG do in its last earnings report?
In its most recent report on Oct 6, 2026 (Q1 2027), Neogen Corporation posted EPS of $0.08 versus the $0.05 estimate, a beat of 50.1%. Revenue was $222.8M against a $208.2M estimate. The stock's 1-day post-earnings move was -2.3%.
How much does NEOG stock move after earnings?
NEOG beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 15.1% (up or down) in the day after earnings.
About Neogen Corporation
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-06 | Q1 2027 | 0.05 | 0.08 | +50.09% | $222.8M | ✅ Beat | -2.34% | -1.92% | — |
| 2026-07-30 | Q4 2026 | 0.05 | 0.09 | +80.00% | $225.3M | ✅ Beat | +22.66% | +21.28% | +24.89% |
| 2026-04-09 | Q3 2026 | 0.04 | 0.09 | +125.00% | $211.2M | ✅ Beat | -2.95% | -8.90% | -10.54% |
| 2026-01-08 | Q2 2026 | 0.06 | 0.10 | +66.67% | $224.7M | ✅ Beat | +31.57% | +27.24% | +46.34% |
| 2025-10-09 | Q1 2026 | 0.03 | 0.04 | +33.33% | $209.2M | ✅ Beat | +16.49% | +2.23% | +2.75% |
| 2025-07-29 | Q4 2025 | 0.08 | 0.05 | -37.50% | $225.5M | ❌ Miss | -10.89% | -13.65% | +3.87% |
| 2025-04-09 | Q3 2025 | 0.13 | 0.10 | -23.08% | $221.0M | ❌ Miss | -28.69% | -29.69% | -14.91% |
| 2025-01-10 | Q2 2025 | 0.10 | 0.11 | +10.00% | $231.3M | ✅ Beat | -5.43% | -11.25% | -20.28% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q1 FY27 · $222.8M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Product | 88.0% | $196.0M | +6.4% | $196.5M | $200.8M | $184.1M | $199.0M |
| Service | 12.0% | $26.8M | +7.0% | $24.5M | $24.7M | $25.1M | $25.7M |
By region
Q1 FY27 · $222.8M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Non-US | 50.6% | $112.7M | +5.2% | $105.6M | $113.0M | $107.1M | $114.3M |
| UNITED STATES | 49.4% | $110.1M | +7.9% | $115.4M | $112.4M | $102.1M | $110.4M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.